On January 1, 2019 (the "Closing Date"), Reliv' International, Inc. entered into, and completed, a Purchase Agreement ("Purchase Agreement") and associated agreements with Nutracom, LLC, pursuant to which Nutracom purchased the following assets used in the contract manufacturing operations of Reliv' International, Inc. (the "Business"). On the Closing Date, Reliv' International, Inc. entered into an employment agreement with Carl W. Hastings to serve as the Chief Scientific Officer. In such role Dr. Hastings will continue in the research and development of the Reliv' International, Inc.'s products and attend select company events.